Early Oseltamivir Treatment of Influenza in Children 1–3 Years of Age: A Randomized Controlled Trial | Zendy

Santtu Hein | Zendy; Heli Silvennoinen | Zendy; Pasi Lehtinen | Zendy; Raija Vainionpää | Zendy; Tero Vahlberg | Zendy; Thedi Ziegler | Zendy; Niina Ikonen | Zendy; Tuomo Puhakka | Zendy; Terho Heikkinen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Early Oseltamivir Treatment of Influenza in Children 1–3 Years of Age: A Randomized Controlled Trial

Author(s) -

Santtu Hein,

Heli Silvennoinen,

Pasi Lehtinen,

Raija Vainionpää,

Tero Vahlberg,

Thedi Ziegler,

Niina Ikonen,

Tuomo Puhakka,

Terho Heikkinen

Publication year - 2010

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/656408

Subject(s) - oseltamivir , medicine , placebo , randomized controlled trial , pediatrics , confidence interval , covid-19 , disease , alternative medicine , pathology , infectious disease (medical specialty)

Oseltamivir provides modest clinical benefits to children with influenza when started within 48 hours of symptom onset. The effectiveness of oseltamivir could be substantially greater if the treatment were started earlier during the course of the illness.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research